首页 | 本学科首页   官方微博 | 高级检索  
检索        

解毒益气活血方治疗严重脓毒症的疗效观察
引用本文:吴艳春,袁新旺,王灵聪,雷澍,智屹惠,江荣林.解毒益气活血方治疗严重脓毒症的疗效观察[J].浙江中医药大学学报,2011,35(1):23-25.
作者姓名:吴艳春  袁新旺  王灵聪  雷澍  智屹惠  江荣林
作者单位:浙江中医药大学附属第一医院,杭州,310006
基金项目:浙江省中医药管理局2009年科研资助项目
摘    要:目的]探讨解毒益气活血方对严重脓毒症患者免疫功能的影响及临床疗效。方法]选择本院ICU严重脓毒症患者51例,随机分为治疗组(25例,采用西医常规治疗加解毒益气活血方)和对照组(26例,采用西医常规治疗)。分析比较两组患者炎症细胞因子(TNF-α、IL-6、IL-10)、CD1+4单核细胞人类白细胞抗原-DR(HLA-DR)的表达百分率、APACHEⅡ评分、机械通气时间、住ICU时间及28天病死率的情况。结果]与对照组相比,治疗组治疗后TNF-α、IL-6、IL-10明显下降,CD1+4单核细胞HLA-DR表达明显上升,机械通气时间和住ICU时间明显缩短,28天病死率明显下降。结论]解毒益气活血方结合西医治疗能调节患者的免疫功能,改善严重脓毒症患者病情和预后。

关 键 词:严重脓毒症  细胞因子  CD1+4单核细胞人类白细胞抗原-DR  解毒益气活血方

Effect of Jiedu Yiqi Huoxue Recipe in Treating Severe Sepsis
Wu Yanchun,Yuan Xinwang,Wang Lingcong,et al The First Affiliated Hospital of Zhejiang Traditional Chinese Medical University,Hangzhou.Effect of Jiedu Yiqi Huoxue Recipe in Treating Severe Sepsis[J].Journal of Zhejiang University of Traditional Chinese Medicine,2011,35(1):23-25.
Authors:Wu Yanchun  Yuan Xinwang  Wang Lingcong  The First Affiliated Hospital of Zhejiang Traditional Chinese Medical University  Hangzhou
Institution:Wu Yanchun,Yuan Xinwang,Wang Lingcong,et al The First Affiliated Hospital of Zhejiang Traditional Chinese Medical University,Hangzhou(310006)
Abstract:Objective] To explore the effect on immunologic function and the therapeutic efficacy of Jiedu Yiqi Huoxue Recipe(JYHR)in treating severe sepsis.Methods] 51 patients with severe sepsis in intensive care unit(ICU) were enrolled and randomly assigned to 2 groups.25 patients in the therapy group were treated with western medicine combined JYHR,26 patients in the control group were treated with western medicine alone.Changes of tumor necrosis factor α(TNF-α),interleukin-6(IL-6),interleukin-10(IL-10),the expression of CD+14 monocyte human leukocyte antigen DR(HLA-DR),APACHE Ⅱ score,the duration of mechanical ventilation,ICU stay time and 28-day mortality were monitored and compared.Results] Compared with the control group,levels of TNF-α,IL-6 and IL-10,the duration of mechanical ventilation,ICU stay time and 28-day mortality were significantly lower in the therapy group,levels of CD+14 monocyte HLA-DR in the therapy group increased significantly.Conclusion] JYHR combined with western medicine can regulate the immunologic function;improve illness state and the outcome of severe sepsis.
Keywords:severe sepsis  Cytokine  CD 14 monocyte human leukocyte antigen DR  Jiedu Yiqi Huoxue Recipe  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号